Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein localization to organelle	USP36 TNIK FLNA SP100 GAK MID2 DISC1 CD2AP BAG4 TOPBP1 VPS54 CBL TERF1 KIAA0753 CEP350 FSIP2 NF1 EGF MDC1 LRRC7	4.69e-06	1091	120	20	GO:0033365
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	TNIK FLNA DISC1 CD2AP BAG4 KIAA0753 CEP350 TBC1D16 FSIP2 CFAP97D1 ARHGAP44 DNAI4 COBL WDR90 KIT	8.14e-06	670	120	15	GO:0120031
GeneOntologyBiologicalProcess	cell projection assembly	TNIK FLNA DISC1 CD2AP BAG4 KIAA0753 CEP350 TBC1D16 FSIP2 CFAP97D1 ARHGAP44 DNAI4 COBL WDR90 KIT	1.06e-05	685	120	15	GO:0030031
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	TNIK SEMA6C FLNA ARHGAP32 GAK DISC1 USH1C ZEB2 TBC1D16 NF1 ARHGAP44 PAK2 COBL LRRC7 ULK1 KIT	3.20e-05	846	120	16	GO:0120035
GeneOntologyBiologicalProcess	regulation of cell projection organization	TNIK SEMA6C FLNA ARHGAP32 GAK DISC1 USH1C ZEB2 TBC1D16 NF1 ARHGAP44 PAK2 COBL LRRC7 ULK1 KIT	4.06e-05	863	120	16	GO:0031344
GeneOntologyBiologicalProcess	neuron projection development	TNIK SEMA6C FLNA ARHGAP32 GAK TRIO DISC1 CD2AP SLITRK4 ARFGEF1 VPS54 USH1C ZEB2 NF1 ARHGAP44 SEC24B PAK2 COBL LRRC7 ULK1	5.00e-05	1285	120	20	GO:0031175
GeneOntologyBiologicalProcess	regulation of neuron projection development	TNIK SEMA6C FLNA ARHGAP32 GAK DISC1 ZEB2 NF1 ARHGAP44 PAK2 COBL LRRC7 ULK1	5.83e-05	612	120	13	GO:0010975
GeneOntologyBiologicalProcess	cell morphogenesis	TNIK SEMA6C FLNA ARHGAP32 TRIO DISC1 CD2AP SLITRK4 VPS54 USH1C JMJD1C ZEB2 ARHGAP44 SEC24B PAK2 COBL ULK1 KIT YTHDF2	5.88e-05	1194	120	19	GO:0000902
GeneOntologyBiologicalProcess	collateral sprouting	CD2AP ZEB2 COBL ULK1	6.20e-05	37	120	4	GO:0048668
GeneOntologyBiologicalProcess	actin cytoskeleton organization	TNIK FLNA MYO5A MYO7B CD2AP BAG4 ARFGEF1 USH1C SPECC1 ZEB2 NF1 ARHGAP44 PAK2 COBL KIT	6.62e-05	803	120	15	GO:0030036
GeneOntologyBiologicalProcess	neural precursor cell proliferation	FLNA GAK DISC1 ZEB2 NCOR2 NF1 EGF VCAN	6.67e-05	233	120	8	GO:0061351
GeneOntologyBiologicalProcess	regulation of nervous system development	TNIK SEMA6C ARHGAP32 DISC1 SLITRK4 ZEB2 NF1 VCAN ULK1 SPEN KIT YTHDF2 ADGRL3	7.21e-05	625	120	13	GO:0051960
GeneOntologyBiologicalProcess	actin filament-based process	TNIK FLNA MYO5A MYO7B CD2AP BAG4 ARFGEF1 USH1C SPECC1 ZEB2 NF1 ARHGAP44 PAK2 COBL CACNA1G KIT	7.80e-05	912	120	16	GO:0030029
GeneOntologyBiologicalProcess	melanocyte migration	ZEB2 KIT	1.00e-04	3	120	2	GO:0097324
GeneOntologyBiologicalProcess	positive regulation of neural precursor cell proliferation	FLNA GAK DISC1 EGF VCAN	1.04e-04	80	120	5	GO:2000179
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	TNIK SEMA6C ARHGAP32 TRIO DISC1 CD2AP SLITRK4 USH1C ZEB2 ARHGAP44 SEC24B PAK2 COBL ULK1	1.15e-04	748	120	14	GO:0048667
GeneOntologyBiologicalProcess	positive regulation of cellular component organization	UNC13B TNIK FLNA ARHGAP32 DISC1 BAG4 SLITRK4 CBL FASLG TERF1 ZEB2 NF1 EGF BTK COBL LRRC7 ULK1 MERTK KIT ADGRL3	1.16e-04	1366	120	20	GO:0051130
GeneOntologyBiologicalProcess	regulation of neural precursor cell proliferation	FLNA GAK DISC1 NF1 EGF VCAN	1.39e-04	135	120	6	GO:2000177
GeneOntologyBiologicalProcess	regulation of small GTPase mediated signal transduction	ARHGAP32 TRIO CD2AP ARFGEF1 CBL MADD NF1 RASAL3 ARHGAP44	1.45e-04	333	120	9	GO:0051056
GeneOntologyBiologicalProcess	regulation of neurogenesis	TNIK SEMA6C ARHGAP32 DISC1 ZEB2 NF1 VCAN ULK1 SPEN KIT YTHDF2	2.12e-04	515	120	11	GO:0050767
GeneOntologyBiologicalProcess	positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction	BAG4 ARFGEF1 CBL EGF MERTK KIT PIK3R5	2.82e-04	217	120	7	GO:0051897
GeneOntologyBiologicalProcess	neuron development	TNIK SEMA6C FLNA ARHGAP32 GAK TRIO DISC1 CD2AP SLITRK4 ARFGEF1 VPS54 USH1C ZEB2 NF1 ARHGAP44 SEC24B PAK2 COBL LRRC7 ULK1	2.88e-04	1463	120	20	GO:0048666
GeneOntologyBiologicalProcess	4-nitrophenol metabolic process	CYP2E1 SULT1A1	3.32e-04	5	120	2	GO:0018960
GeneOntologyBiologicalProcess	viral transcription	SP100 MID2 RRP1B CHD1	3.63e-04	58	120	4	GO:0019083
GeneOntologyBiologicalProcess	protein localization to microtubule cytoskeleton	MID2 DISC1 KIAA0753 CEP350	3.87e-04	59	120	4	GO:0072698
GeneOntologyBiologicalProcess	phosphatidylinositol 3-kinase/protein kinase B signal transduction	CD2AP BAG4 ARFGEF1 CBL NF1 EGF MERTK KIT PIK3R5	4.00e-04	382	120	9	GO:0043491
GeneOntologyCellularComponent	actin cytoskeleton	FLNA ARHGAP32 MYO5A MYO7B CD2AP APC2 TOPBP1 C10orf90 SPECC1 INTS6 SH3PXD2A COBL LRRC7	3.55e-05	576	123	13	GO:0015629
GeneOntologyCellularComponent	fibrillar center	ARHGAP32 SELENBP1 CD2AP TERF1 SPECC1 NUFIP1 KIT	3.88e-05	156	123	7	GO:0001650
GeneOntologyCellularComponent	anchoring junction	FLNA GAK THEMIS PNN CD2AP LCP2 MAST2 CBL SH3PXD2A PI4KA MDC1 PAK2 NHS LRRC7 KIT ADGRL3 SYMPK	5.82e-05	976	123	17	GO:0070161
GeneOntologyCellularComponent	nuclear protein-containing complex	FLNA SP100 PMS2 THEMIS PNN TOPBP1 ARFGEF1 BRMS1L BCOR TERF1 JMJD1C NUFIP1 NCOR2 GTF2E1 INTS6 DBF4 ASCC2 KMT2A SRRM2 SYMPK	1.53e-04	1377	123	20	GO:0140513
GeneOntologyCellularComponent	actin filament	FLNA MYO5A CD2AP APC2 SPECC1 COBL	2.28e-04	146	123	6	GO:0005884
GeneOntologyCellularComponent	cell-cell junction	FLNA THEMIS PNN CD2AP LCP2 PAK2 NHS LRRC7 KIT ADGRL3 SYMPK	7.43e-04	591	123	11	GO:0005911
GeneOntologyCellularComponent	nuclear body	USP36 SP100 PNN KAT6A TOPBP1 TERF1 NCOR2 DBF4 SETBP1 MDC1 ASCC2 NHS SRRM2 SYMPK	8.69e-04	903	123	14	GO:0016604
HumanPheno	Anteverted ears	KAT6A BCOR NHS CACNA1G	4.15e-06	14	43	4	HP:0040080
HumanPheno	Abnormality of pigmentation	FLNA PMS2 SLC29A3 COPB1 MYO5A APC2 KAT6A USH1C CBL JMJD1C ZEB2 ZNF469 NF1 BTK SETBP1 SPEN KIT	5.01e-06	625	43	17	HP:0200045
HumanPheno	Abnormal nasal tip morphology	FLNA TRIO KAT6A BCOR JMJD1C ZEB2 MADD KIAA0753 NF1 SETBP1 KMT2A SRRM2 SPEN	9.96e-06	386	43	13	HP:0000436
HumanPheno	Large face	FLNA MID2 APC2 KAT6A BCOR JMJD1C KIAA0753 NF1 SETBP1 NHS SPEN	1.49e-05	283	43	11	HP:0100729
HumanPheno	Dilatation of the renal pelvis	FLNA APC2 KAT6A BCOR CBL ZEB2 KIAA0753 NF1 PI4KA SETBP1 SPEN	1.88e-05	290	43	11	HP:0010946
HumanPheno	Abnormal renal pelvis morphology	FLNA APC2 KAT6A BCOR CBL ZEB2 KIAA0753 NF1 PI4KA SETBP1 SPEN	2.59e-05	300	43	11	HP:0010944
HumanPheno	Abnormality of skin pigmentation	FLNA PMS2 SLC29A3 COPB1 MYO5A APC2 KAT6A CBL JMJD1C ZEB2 NF1 BTK SETBP1 SPEN KIT	2.82e-05	561	43	15	HP:0001000
HumanPheno	Abnormal pulmonary valve morphology	FLNA SLC29A3 KAT6A BCOR CBL JMJD1C ZEB2 ZNF469 NF1	3.02e-05	198	43	9	HP:0001641
HumanPheno	Highly arched eyebrow	TRIO KAT6A BCOR CBL ZEB2 MADD KIAA0753 KMT2A SPEN	4.13e-05	206	43	9	HP:0002553
HumanPheno	Strabismus	FLNA MID2 TRIO MYO5A APC2 KAT6A BCOR CBL JMJD1C ZEB2 MADD KIAA0753 NF1 PI4KA SETBP1 PAK2 KMT2A NHS CACNA1G SRRM2 SPEN PIK3R5	4.15e-05	1159	43	22	HP:0000486
HumanPheno	Long face	MID2 APC2 KAT6A BCOR JMJD1C KIAA0753 NF1 SETBP1 NHS SPEN	4.19e-05	259	43	10	HP:0000276
HumanPheno	Patent ductus arteriosus	FLNA SLC29A3 TRIO APC2 KAT6A BCOR CBL JMJD1C ZEB2 PAK2 KMT2A SPEN	4.82e-05	382	43	12	HP:0001643
HumanPheno	Neoplasm by histology	FLNA PMS2 APC2 FASLG SSX2 ZEB2 KIAA0753 NF1 SETBP1 PAK2 SPEN KIT	4.95e-05	383	43	12	HP:0011792
HumanPheno	Abnormal hallux morphology	FLNA SLC29A3 KAT6A BCOR ZEB2 KIAA0753 ZNF469 SETBP1 KMT2A	5.19e-05	212	43	9	HP:0001844
HumanPheno	Abnormal eyebrow morphology	SLC29A3 TRIO MYO5A KAT6A CHD1 BCOR CBL ZEB2 MADD KIAA0753 NF1 PI4KA SETBP1 KMT2A SPEN KIT	6.08e-05	674	43	16	HP:0000534
HumanPheno	Abnormal conjugate eye movement	FLNA MID2 TRIO MYO5A APC2 KAT6A BCOR CBL JMJD1C ZEB2 MADD KIAA0753 NF1 PI4KA SETBP1 PAK2 KMT2A NHS CACNA1G SRRM2 SPEN PIK3R5	7.13e-05	1198	43	22	HP:0000549
HumanPheno	Teratoma	APC2 SETBP1 KIT	8.82e-05	11	43	3	HP:0009792
HumanPheno	Abnormality of the chin	FLNA TRIO APC2 KAT6A CHD1 ZEB2 MADD SETBP1 NHS CACNA1G SRRM2 SPEN	9.42e-05	409	43	12	HP:0000306
HumanPheno	Abnormal hair morphology	FLNA SLC29A3 COPB1 TRIO MYO5A APC2 KAT6A CHD1 BCOR CBL JMJD1C ZEB2 MADD KIAA0753 ZNF469 NF1 PI4KA BTK SETBP1 PAK2 KMT2A CACNA1G SPEN KIT	1.07e-04	1424	43	24	HP:0001595
HumanPheno	Myeloid leukemia	CBL NF1 SETBP1 KIT	1.17e-04	31	43	4	HP:0012324
HumanPheno	Pointed chin	FLNA KAT6A CHD1 ZEB2 MADD SETBP1 SPEN	1.31e-04	138	43	7	HP:0000307
HumanPheno	Long philtrum	FLNA TRIO BCOR CBL JMJD1C MADD KIAA0753 NF1 SETBP1 KMT2A SPEN KIT	1.49e-04	429	43	12	HP:0000343
HumanPheno	Abnormality of the philtrum	FLNA MID2 TRIO KAT6A BCOR CBL JMJD1C ZEB2 MADD KIAA0753 NF1 SETBP1 KMT2A SRRM2 SPEN KIT	1.51e-04	726	43	16	HP:0000288
HumanPheno	Overlapping fingers	FLNA MADD PI4KA SETBP1	1.91e-04	35	43	4	HP:0010557
HumanPheno	Abnormal enteric ganglion morphology	APC2 BCOR JMJD1C ZEB2 KIAA0753 SETBP1 KIT	2.21e-04	150	43	7	HP:0004362
HumanPheno	Aganglionic megacolon	APC2 BCOR JMJD1C ZEB2 KIAA0753 SETBP1 KIT	2.21e-04	150	43	7	HP:0002251
HumanPheno	Megacolon	APC2 BCOR JMJD1C ZEB2 KIAA0753 SETBP1 KIT	2.21e-04	150	43	7	HP:6000852
HumanPheno	Abnormal autonomic nervous system morphology	APC2 BCOR JMJD1C ZEB2 KIAA0753 SETBP1 KIT	2.30e-04	151	43	7	HP:0012331
HumanPheno	Abnormal enteric nervous system morphology	APC2 BCOR JMJD1C ZEB2 KIAA0753 SETBP1 KIT	2.30e-04	151	43	7	HP:0025028
HumanPheno	Abnormal hair pattern	FLNA SLC29A3 COPB1 TRIO APC2 CBL ZEB2 MADD KIAA0753 NF1 SETBP1 KMT2A CACNA1G SPEN KIT	2.47e-04	676	43	15	HP:0010720
HumanPheno	macules	PMS2 COPB1 CBL JMJD1C ZEB2 NF1 BTK SETBP1 KIT	2.65e-04	262	43	9	HP:0200031
HumanPheno	Pectus excavatum	FLNA TRIO APC2 KAT6A BCOR CBL ZEB2 NF1 PI4KA KMT2A	2.67e-04	323	43	10	HP:0000767
HumanPheno	Hydronephrosis	FLNA APC2 KAT6A BCOR ZEB2 KIAA0753 NF1 SETBP1 SPEN	2.80e-04	264	43	9	HP:0000126
HumanPheno	Abnormal eyelid morphology	FLNA SLC29A3 COPB1 TRIO MYO5A APC2 KAT6A CHD1 BCOR CBL JMJD1C ZEB2 MADD KIAA0753 ZNF469 NF1 SETBP1 PAK2 KMT2A CACNA1G SRRM2 SPEN KIT	2.89e-04	1408	43	23	HP:0000492
HumanPheno	Abnormal helix morphology	FLNA TRIO KAT6A BCOR CBL JMJD1C NF1 SETBP1	3.24e-04	212	43	8	HP:0011039
HumanPheno	Epicanthus	FLNA TRIO KAT6A CBL JMJD1C ZEB2 MADD KIAA0753 ZNF469 NF1 PAK2 KMT2A SRRM2 SPEN	3.25e-04	614	43	14	HP:0000286
HumanPheno	Abnormal nasal septum morphology	TRIO KAT6A ZEB2 MADD NF1 KMT2A	3.58e-04	115	43	6	HP:0000419
HumanPheno	Abnormal pulmonary valve physiology	FLNA SLC29A3 KAT6A BCOR ZEB2 ZNF469 NF1	3.68e-04	163	43	7	HP:0031654
HumanPheno	Abnormal sternum morphology	FLNA TRIO APC2 KAT6A BCOR CBL ZEB2 KIAA0753 NF1 PI4KA SETBP1 KMT2A	3.83e-04	474	43	12	HP:0000766
HumanPheno	Broad hallux	FLNA BCOR ZEB2 KIAA0753 SETBP1	4.00e-04	76	43	5	HP:0010055
HumanPheno	Sacrococcygeal teratoma	APC2 SETBP1	4.13e-04	4	43	2	HP:0030736
HumanPheno	Abnormality of refraction	FLNA MYO5A APC2 KAT6A USH1C ZEB2 MADD KIAA0753 ZNF469 VCAN SETBP1 PAK2 CACNA1G SRRM2 SPEN	4.20e-04	709	43	15	HP:0000539
HumanPheno	Syndactyly	FLNA TRIO APC2 KAT6A BMS1 BCOR ZEB2 KIAA0753 SETBP1 KMT2A CACNA1G	5.03e-04	417	43	11	HP:0001159
HumanPheno	Abnormal intestine morphology	FLNA PMS2 SLC29A3 COPB1 TRIO CD2AP APC2 KAT6A BCOR CBL FASLG JMJD1C ZEB2 MADD KIAA0753 PI4KA BTK SETBP1 PAK2 KMT2A CACNA1G SPEN KIT	5.10e-04	1459	43	23	HP:0002242
HumanPheno	Localized skin lesion	FLNA PMS2 SLC29A3 COPB1 KAT6A BMS1 BCOR CBL JMJD1C ZEB2 ZNF469 NF1 BTK SETBP1 KMT2A SPEN KIT	5.54e-04	897	43	17	HP:0011355
HumanPheno	Midface retrusion	FLNA TRIO KAT6A CHD1 CBL NF1 SETBP1 PAK2 SPEN	5.76e-04	291	43	9	HP:0011800
HumanPheno	Hypertrichosis	FLNA SLC29A3 COPB1 TRIO ZEB2 KIAA0753 SETBP1 KMT2A CACNA1G SPEN KIT	5.92e-04	425	43	11	HP:0000998
HumanPheno	Downslanted palpebral fissures	FLNA SLC29A3 TRIO APC2 CHD1 CBL JMJD1C ZEB2 NF1 SETBP1 KMT2A SPEN	5.92e-04	497	43	12	HP:0000494
HumanPheno	Flushing	APC2 CBL NF1 KIT	6.03e-04	47	43	4	HP:0031284
HumanPheno	Glioma	PMS2 APC2 NF1 SETBP1	6.54e-04	48	43	4	HP:0009733
HumanPheno	Pes planus	FLNA SLC29A3 COPB1 TRIO APC2 KAT6A ZEB2 ZNF469 KMT2A SPEN	7.11e-04	365	43	10	HP:0001763
HumanPheno	Diagnostic behavioral phenotype	TRIO APC2 KAT6A CHD1 BCOR USH1C JMJD1C MADD NF1 SETBP1 PAK2 KMT2A NHS SRRM2 SPEN	7.42e-04	747	43	15	HP:0025783
HumanPheno	Broad toe	FLNA BCOR ZEB2 KIAA0753 SETBP1	7.48e-04	87	43	5	HP:0001837
HumanPheno	Delayed eruption of teeth	FLNA SLC29A3 TRIO APC2 BCOR ZEB2 SETBP1	7.90e-04	185	43	7	HP:0000684
HumanPheno	Toe syndactyly	FLNA TRIO APC2 KAT6A BMS1 BCOR KIAA0753 KMT2A	8.32e-04	244	43	8	HP:0001770
HumanPheno	Short attention span	TNIK PMS2 TRIO APC2 CBL JMJD1C MADD NF1 SETBP1 KMT2A SRRM2 SPEN	8.47e-04	517	43	12	HP:0000736
HumanPheno	Abnormal large intestine morphology	PMS2 COPB1 TRIO APC2 BCOR FASLG JMJD1C ZEB2 KIAA0753 PI4KA SETBP1 CACNA1G KIT	8.49e-04	594	43	13	HP:0002250
HumanPheno	Autistic behavior	TRIO APC2 KAT6A CHD1 BCOR JMJD1C MADD NF1 SETBP1 PAK2 KMT2A NHS SRRM2 SPEN	9.04e-04	678	43	14	HP:0000729
HumanPheno	Abnormal earlobe morphology	KAT6A JMJD1C ZEB2 SETBP1 SRRM2 SPEN	9.11e-04	137	43	6	HP:0000363
HumanPheno	Pulmonic stenosis	SLC29A3 KAT6A BCOR ZEB2 ZNF469 NF1	9.47e-04	138	43	6	HP:0001642
HumanPheno	Delayed speech and language development	TNIK FLNA COPB1 TRIO APC2 KAT6A ARFGEF1 CBL ZEB2 MADD KIAA0753 NF1 PI4KA BTK SETBP1 KMT2A CACNA1G SRRM2 SPEN	9.56e-04	1123	43	19	HP:0000750
HumanPheno	Abnormality of the dentition	FLNA SLC29A3 TRIO APC2 KAT6A BCOR USH1C JMJD1C ZEB2 MADD KIAA0753 ZNF469 NF1 SETBP1 PAK2 KMT2A NHS SPEN	9.58e-04	1030	43	18	HP:0000164
HumanPheno	Neuroepithelial neoplasm	PMS2 APC2 NF1 SETBP1 SPEN	9.65e-04	92	43	5	HP:0030063
HumanPheno	Reduced attention regulation	TNIK PMS2 TRIO APC2 CBL JMJD1C MADD NF1 SETBP1 KMT2A SRRM2 SPEN	9.88e-04	526	43	12	HP:5200044
HumanPheno	Abnormal serum mast cell beta-tryptase concentration	CBL KIT	1.02e-03	6	43	2	HP:0031900
HumanPheno	Elevated total serum tryptase	CBL KIT	1.02e-03	6	43	2	HP:0031901
HumanPheno	Upper eyelid edema	SLC29A3 KAT6A	1.02e-03	6	43	2	HP:0012724
HumanPheno	Congenital malformation of the great arteries	FLNA SLC29A3 TRIO APC2 KAT6A BCOR CBL JMJD1C ZEB2 PAK2 KMT2A SPEN	1.04e-03	529	43	12	HP:0011603
HumanPheno	Short philtrum	MID2 TRIO KAT6A JMJD1C ZEB2 MADD SETBP1 SPEN	1.06e-03	253	43	8	HP:0000322
HumanPheno	Neuroectodermal neoplasm	PMS2 APC2 NF1 SETBP1 SPEN	1.06e-03	94	43	5	HP:0030061
HumanPheno	Nervous tissue neoplasm	PMS2 APC2 NF1 SETBP1 SPEN	1.06e-03	94	43	5	HP:0030060
HumanPheno	Neoplasm of the nervous system	PMS2 APC2 KIAA0753 NF1 SETBP1 SPEN KIT	1.08e-03	195	43	7	HP:0004375
HumanPheno	Astrocytoma	PMS2 APC2 NF1	1.13e-03	25	43	3	HP:0009592
HumanPheno	Sandal gap	FLNA TRIO KAT6A BCOR SETBP1	1.17e-03	96	43	5	HP:0001852
HumanPheno	Dental crowding	TRIO BCOR ZEB2 MADD SETBP1 SPEN	1.18e-03	144	43	6	HP:0000678
HumanPheno	Abnormal bleeding	FLNA PMS2 BMS1 BCOR LCP2 CBL FASLG JMJD1C ZEB2 ZNF469 NF1 KIT	1.19e-03	537	43	12	HP:0001892
HumanPheno	Abnormal columella morphology	TRIO KAT6A ZEB2 MADD KMT2A	1.23e-03	97	43	5	HP:0009929
HumanPheno	Atrial septal defect	FLNA SLC29A3 TRIO APC2 KAT6A BCOR CBL JMJD1C ZEB2 NF1 SETBP1 KMT2A	1.27e-03	541	43	12	HP:0001631
HumanPheno	Abnormality of the atrial septum	FLNA SLC29A3 TRIO APC2 KAT6A BCOR CBL JMJD1C ZEB2 NF1 SETBP1 KMT2A	1.27e-03	541	43	12	HP:0001630
HumanPheno	Narrow palate	FLNA COPB1 APC2 BCOR MADD SETBP1 SPEN	1.33e-03	202	43	7	HP:0000189
HumanPheno	Abnormal atrial septum morphology	FLNA SLC29A3 TRIO APC2 KAT6A BCOR CBL JMJD1C ZEB2 NF1 SETBP1 KMT2A	1.33e-03	544	43	12	HP:0011994
HumanPheno	Abnormal anterior eye segment morphology	FLNA SLC29A3 COPB1 MYO5A APC2 KAT6A BCOR USH1C CBL JMJD1C ZEB2 KIAA0753 ZNF469 NF1 VCAN BTK SETBP1 PAK2 NHS MERTK SPEN KIT	1.34e-03	1450	43	22	HP:0004328
HumanPheno	Malignant neoplasm of the central nervous system	PMS2 APC2 NF1 SETBP1 SPEN	1.34e-03	99	43	5	HP:0100836
HumanPheno	Hyperpigmentation of the skin	PMS2 SLC29A3 COPB1 MYO5A APC2 CBL NF1 SETBP1 KIT	1.36e-03	328	43	9	HP:0000953
HumanPheno	Abnormality of the palpebral fissures	FLNA SLC29A3 COPB1 TRIO APC2 CHD1 BCOR CBL JMJD1C ZEB2 MADD NF1 SETBP1 KMT2A CACNA1G SPEN	1.39e-03	880	43	16	HP:0008050
HumanPheno	Generalized hypertrichosis	SETBP1 KMT2A	1.42e-03	7	43	2	HP:0004554
HumanPheno	Hyperpigmented papule	FLNA KIT	1.42e-03	7	43	2	HP:0025473
HumanPheno	Constipation	FLNA PMS2 TRIO APC2 JMJD1C ZEB2 MADD PAK2 KMT2A SPEN KIT	1.42e-03	472	43	11	HP:0002019
MousePheno	abnormal spleen size	BICDL2 SLC29A3 GAK SELENBP1 MID2 CD2AP BAG4 KAT6A CBL FASLG NCOR2 ZSCAN10 SULT1A1 VCAN BTK MDC1 SEC24B ASCC2 KMT2A ULK1 MERTK KIT	1.96e-05	1203	97	22	MP:0002224
MousePheno	abnormal ear pigmentation	MYO5A CBL NF1 KIT	2.90e-05	26	97	4	MP:0000015
MousePheno	abnormal thymus morphology	PMS2 SLC29A3 GAK THEMIS SELENBP1 CD2AP BAG4 KAT6A LCP2 CBL FASLG SULT1A1 SH3PXD2A MDC1 COBL KIT	3.14e-05	717	97	16	MP:0000703
MousePheno	abnormal outer ear skin morphology	MYO5A CBL NF1 KIT	3.38e-05	27	97	4	MP:0030530
MousePheno	abnormal foot pigmentation	MYO5A CBL NF1 KIT	3.93e-05	28	97	4	MP:0009379
MousePheno	liver hypoplasia	KAT6A NF1 SH3PXD2A KMT2A SPEN	6.86e-05	62	97	5	MP:0000600
MousePheno	abnormal head skin morphology	MYO5A CBL NF1 KIT	8.61e-05	34	97	4	MP:0030529
MousePheno	abnormal positive T cell selection	THEMIS LCP2 CD74	1.12e-04	14	97	3	MP:0004919
MousePheno	abnormal lymphopoiesis	PMS2 THEMIS KAT6A LCP2 CBL FASLG BTK MDC1 KMT2A CD74 SPEN KIT	1.43e-04	490	97	12	MP:0002401
MousePheno	abnormal tail pigmentation	MYO5A CBL NF1 KIT	1.49e-04	39	97	4	MP:0005174
MousePheno	abnormal outer ear morphology	MYO5A CBL NF1 KMT2A TSHZ1 KIT	1.76e-04	119	97	6	MP:0002177
MousePheno	lethality throughout fetal growth and development	FLNA TRIO KAT6A CBL NCOR2 NF1 VCAN SEC24B KMT2A SPEN KIT	2.09e-04	435	97	11	MP:0006208
MousePheno	abnormal leukopoiesis	PMS2 SLC29A3 THEMIS KAT6A LCP2 CBL FASLG BTK MDC1 KMT2A CD74 SPEN KIT	2.26e-04	594	97	13	MP:0005460
MousePheno	abnormal prevertebral ganglion morphology	NF1 SH3PXD2A	2.83e-04	4	97	2	MP:0008316
MousePheno	transposition of great arteries	PNN KAT6A SH3PXD2A SEC24B	3.09e-04	47	97	4	MP:0004110
MousePheno	abnormal immune system development	PMS2 SLC29A3 THEMIS KAT6A LCP2 CBL FASLG BTK MDC1 KMT2A CD74 SPEN KIT	3.22e-04	616	97	13	MP:0020981
MousePheno	abnormal cardiac outflow tract development	FLNA PNN NF1 SH3PXD2A VCAN SEC24B	3.36e-04	134	97	6	MP:0006126
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	9.79e-07	4	118	3	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	9.79e-07	4	118	3	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	9.79e-07	4	118	3	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	9.79e-07	4	118	3	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	9.79e-07	4	118	3	IPR015753
Domain	BRCT	TOPBP1 DBF4 MDC1	2.21e-04	19	118	3	PF00533
Domain	BRCT	TOPBP1 DBF4 MDC1	3.47e-04	22	118	3	SM00292
Domain	-	TOPBP1 DBF4 MDC1	3.97e-04	23	118	3	3.40.50.10190
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGAP32 TRIO CD2AP MAST2 CBL SPECC1 MADD KIAA0753 CEP350 FSIP2 NF1 SH3PXD2A PI4KA SEC24B KMT2A COBL NHS TANC1 SRRM2 YTHDF2	3.21e-11	861	124	20	36931259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	USP36 ARHGAP32 PMS2 TRIO MYO5A RRP1B BMS1 BCOR MADD KIAA0753 CEP350 NCOR2 GTF2E1 PI4KA SEC24B NHS TANC1 SRRM2 USP1 SYMPK	1.01e-09	1049	124	20	27880917
Pubmed	Analysis of the multi-copy gene family FAM90A as a copy number variant in different ethnic backgrounds.	FAM90A14 FAM90A17 FAM90A23 FAM90A8 FAM90A16	1.70e-08	23	124	5	18602769
Pubmed	Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events.	FAM90A14 FAM90A17 FAM90A23 FAM90A8 FAM90A16	2.67e-08	25	124	5	17684299
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ARHGAP32 DISC1 APC2 NCOR2 ZNF469 RASAL3 SETBP1 MDC1 TSHZ1 WDR90 SPEN ADGRL3	5.01e-08	430	124	12	35044719
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	USP36 FLNA PNN RRP1B CD2AP TOPBP1 CHD1 BCOR SSX2 JMJD1C NCOR2 MDC1 KMT2A SRRM2 SPEN YTHDF2 SYMPK	5.41e-08	954	124	17	36373674
Pubmed	A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton.	CD2AP CBL EGF SH3PXD2A	7.45e-08	12	124	4	12672817
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	FLNA GAK PNN CD2AP BCOR CBL JMJD1C MDC1 SEC24B PAK2 KMT2A SPEN SYMPK	9.13e-08	549	124	13	38280479
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	GAK PNN TRIO RRP1B CHD1 CBL SPECC1 NCOR2 NF1 EGF SH3PXD2A BTK KMT2A ULK1 MERTK YTHDF2	1.65e-07	910	124	16	36736316
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	1.76e-07	4	124	3	22419166
Pubmed	Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.	KAT6A KMT2A SYMPK	1.76e-07	4	124	3	23994619
Pubmed	A human MAP kinase interactome.	FLNA ARHGAP32 SP100 LCP2 CBL TERF1 MADD CEP350 RASAL3 BTK PAK2 COBL	1.88e-07	486	124	12	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UNC13B TNIK ZEB2 MADD SNX13 COBL LRRC7 ULK1 SRRM2 SPEN ADGRL3	2.55e-07	407	124	11	12693553
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	BCOR JMJD1C ZEB2 KIAA0753 CEP350 NCOR2 SEC24B SPEN	3.44e-07	184	124	8	32908313
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	UNC13B SEMA6C FLNA TRIO KAT6A MAST2 MADD TBC1D16 NCOR2 PI4KA ARHGAP44 COBL WDR90 TANC1 ULK1 SPEN SYMPK	4.29e-07	1105	124	17	35748872
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	FLNA SP100 CD2AP BCOR JMJD1C NCOR2 GTF2E1 SEC24B PAK2 YTHDF2 SYMPK	6.02e-07	444	124	11	34795231
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FLNA COPB1 PNN MYO5A RRP1B BMS1 CHD1 NF1 MDC1 KMT2A SRRM2 SPEN SYMPK	6.53e-07	653	124	13	22586326
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	UNC13B USP36 PNN RRP1B MAST2 JMJD1C NF1 MDC1 SRRM2 SPEN	7.34e-07	361	124	10	26167880
Pubmed	Human transcription factor protein interaction networks.	ARHGAP32 ATXN7L2 COPB1 PNN MYO5A RRP1B BMS1 BRMS1L BCOR JMJD1C ZEB2 NCOR2 MDC1 SEC24B KMT2A SRRM2 SPEN YTHDF2 SYMPK	7.68e-07	1429	124	19	35140242
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	FLNA ARHGAP32 CD2AP CBL SPECC1 PI4KA SEC24B VSIG10L PAK2 NHS LRRC7 TANC1	9.20e-07	565	124	12	25468996
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	USP36 FLNA PNN RRP1B CEP350 NF1 KMT2A SRRM2	9.34e-07	210	124	8	16565220
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	USP36 MYO5A RRP1B CD2AP BMS1 TOPBP1 CHD1 BCOR SPECC1 RBM23 INTS6 PI4KA MDC1 SEC24B ASCC2 KMT2A TANC1 SPEN MRPL9	1.53e-06	1497	124	19	31527615
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ARHGAP32 MAST2 SNX13 KIAA0753 ULK1 ADGRL3	1.75e-06	101	124	6	9872452
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	RRP1B KAT6A TOPBP1 CHD1 BCOR JMJD1C ZEB2 FSIP2 GTF2E1 MDC1 KMT2A SPEN	1.97e-06	608	124	12	36089195
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FLNA PNN MYO5A MYO7B BCOR MAST2 MDC1 SRRM2	2.10e-06	234	124	8	36243803
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	RRP1B CHD1 BCOR ZEB2 SPEN YTHDF2	2.73e-06	109	124	6	33554859
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	USP36 EME1 ATXN7L2 PNN RRP1B TOPBP1 BRMS1L BCOR TERF1 JMJD1C NCOR2 INTS6 MDC1 KMT2A SRRM2 SPEN SYMPK	3.65e-06	1294	124	17	30804502
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	PMS2 ARFGEF1 CHD1 JMJD1C MDC1 KMT2A SRRM2 SPEN SYMPK	3.98e-06	341	124	9	32971831
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	USP36 CDS1 GAK ARFGEF1 SEC24B KMT2A SRRM2	4.97e-06	186	124	7	33637726
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A	5.21e-06	10	124	3	23064749
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	FLNA EME1 TOPBP1 BCOR SPECC1 ZEB2 CEP350 MDC1 SYMPK	5.76e-06	357	124	9	37059091
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CDS1 MID2 TRIO MYO5A CD2AP KAT6A VPS54 SSX2 JMJD1C NCOR2 INTS6 SH3PXD2A SETBP1 ARHGAP44 COBL LRRC7 TANC1 CYP4F11	5.82e-06	1489	124	18	28611215
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	FLNA COPB1 JMJD1C NCOR2 GTF2E1 MDC1 SYMPK	8.80e-06	203	124	7	22083510
Pubmed	Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells.	FLNA PNN CD2AP CBL PAK2 SRRM2	1.02e-05	137	124	6	37039823
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP36 SP100 ATXN7L2 BAG4 KAT6A BRMS1L BCOR MAST2 NUFIP1 NCOR2 INTS6 ZNF469 RASAL3 TANC1 SRRM2	1.09e-05	1116	124	15	31753913
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ARHGAP32 ATXN7L2 MID2 COPB1 BEND5 KAT6A BCOR USH1C CEP350 CACNA1G SPEN	1.21e-05	608	124	11	16713569
Pubmed	Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.	LCP2 CBL	1.26e-05	2	124	2	19074136
Pubmed	Human CYP2E1-dependent and human sulfotransferase 1A1-modulated induction of micronuclei by benzene and its hydroxylated metabolites in Chinese hamster V79-derived cells.	CYP2E1 SULT1A1	1.26e-05	2	124	2	25771868
Pubmed	Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.	CBL BTK	1.26e-05	2	124	2	10826882
Pubmed	Structure of Myo7b/USH1C complex suggests a general PDZ domain binding mode by MyTH4-FERM myosins.	MYO7B USH1C	1.26e-05	2	124	2	28439001
Pubmed	The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function.	TNIK DISC1	1.26e-05	2	124	2	20838393
Pubmed	Solution structure of the second SH3 domain of human CMS and a newly identified binding site at the C-terminus of c-Cbl.	CD2AP CBL	1.26e-05	2	124	2	17188587
Pubmed	Structural insights into recognition of MDC1 by TopBP1 in DNA replication checkpoint control.	TOPBP1 MDC1	1.26e-05	2	124	2	23891287
Pubmed	Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit.	USP1 KIT	1.26e-05	2	124	2	35045360
Pubmed	The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction.	CD2AP CBL	1.26e-05	2	124	2	11067845
Pubmed	Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.	CBL KIT	1.26e-05	2	124	2	16780420
Pubmed	The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase.	CBL BTK	1.26e-05	2	124	2	7629518
Pubmed	Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.	NF1 KIT	1.26e-05	2	124	2	18984156
Pubmed	Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.	NF1 KIT	1.26e-05	2	124	2	12393498
Pubmed	Human cytochrome P450 2E1 and sulfotransferase 1A1 coexpressed in Chinese hamster V79 cells enhance spontaneous mutagenesis.	CYP2E1 SULT1A1	1.26e-05	2	124	2	19484729
Pubmed	CBL mutations in infant acute lymphoblastic leukaemia.	CBL KMT2A	1.26e-05	2	124	2	21988239
Pubmed	Feedback activation of neurofibromin terminates growth factor-induced Ras activation.	NF1 EGF	1.26e-05	2	124	2	26861207
Pubmed	Estradiol protects dermal hyaluronan/versican matrix during photoaging by release of epidermal growth factor from keratinocytes.	EGF VCAN	1.26e-05	2	124	2	22493503
Pubmed	Mechanistic Basis of Organization of the Harmonin/USH1C-Mediated Brush Border Microvilli Tip-Link Complex.	MYO7B USH1C	1.26e-05	2	124	2	26812017
Pubmed	Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.	CBL KMT2A	1.26e-05	2	124	2	12696071
Pubmed	SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.	CBL BTK	1.26e-05	2	124	2	9408950
Pubmed	The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin.	FLNA TRIO	1.26e-05	2	124	2	11146652
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	FLNA PMS2 PNN RRP1B TOPBP1 CBL PAK2 NHS SRRM2 SPEN	1.37e-05	503	124	10	16964243
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	UNC13B PMS2 COPB1 TRIO MYO5A APC2 VPS54 TERF1 SPECC1 ZEB2 MADD NUFIP1 CEP350 PAK2 CD74 MERTK	1.41e-05	1285	124	16	35914814
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	FLNA MYO7B USH1C COBL	2.05e-05	45	124	4	22114352
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP36 SEMA6C RRP1B BMS1 TOPBP1 BCOR SETBP1 MDC1 CACNA1G WDR90	2.11e-05	529	124	10	14621295
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FLNA EME1 PNN BCOR NCOR2 NF1 DBF4 MDC1 KMT2A SRRM2 SPEN SYMPK	2.22e-05	774	124	12	15302935
Pubmed	Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network.	CDS1 FAM90A14 FAM90A17 FAM90A23 MERTK FAM90A8	2.83e-05	164	124	6	22967998
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	USP36 TNIK FLNA GAK COPB1 PNN CHD1 BCOR GTF2E1 SEC24B PAK2 KMT2A YTHDF2	3.07e-05	934	124	13	33916271
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MYO5A SPECC1 MADD NF1 SH3PXD2A LRRC7 SRRM2 ADGRL3	3.65e-05	347	124	8	17114649
Pubmed	Oocytes can repair DNA damage during meiosis via a microtubule-dependent recruitment of CIP2A-MDC1-TOPBP1 complex from spindle pole to chromosomes.	TOPBP1 MDC1	3.77e-05	3	124	2	36999590
Pubmed	Impact of FLT3 mutations and promyelocytic leukaemia-breakpoint on clinical characteristics and prognosis in acute promyelocytic leukaemia.	KMT2A KIT	3.77e-05	3	124	2	16029447
Pubmed	Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor.	CBL EGF	3.77e-05	3	124	2	14627991
Pubmed	Structural insights into the recruitment of SMRT by the corepressor SHARP under phosphorylative regulation.	NCOR2 SPEN	3.77e-05	3	124	2	24268649
Pubmed	Mdc1 modulates the interaction between TopBP1 and the MRN complex during DNA damage checkpoint responses.	TOPBP1 MDC1	3.77e-05	3	124	2	27590578
Pubmed	Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.	NF1 KIT	3.77e-05	3	124	2	10620616
Pubmed	CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.	KMT2A KIT	3.77e-05	3	124	2	32549410
Pubmed	Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.	CBL EGF	3.77e-05	3	124	2	15475003
Pubmed	The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.	CBL KIT	3.77e-05	3	124	2	23783394
Pubmed	Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.	ZEB2 VCAN	3.77e-05	3	124	2	24005989
Pubmed	CD2AP/CMS regulates endosome morphology and traffic to the degradative pathway through its interaction with Rab4 and c-Cbl.	CD2AP CBL	3.77e-05	3	124	2	12559036
Pubmed	Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.	NF1 KIT	3.77e-05	3	124	2	28296713
Pubmed	Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases.	MYO5A KMT2A	3.77e-05	3	124	2	8327517
Pubmed	Disrupted-in-Schizophrenia 1-mediated axon guidance involves TRIO-RAC-PAK small GTPase pathway signaling.	TRIO DISC1	3.77e-05	3	124	2	21422296
Pubmed	E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.	CBL KIT	3.77e-05	3	124	2	19734451
Pubmed	A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.	BCOR NCOR2	3.77e-05	3	124	2	23911289
Pubmed	Loss of SLP-76 expression within myeloid cells confers resistance to neutrophil-mediated tissue damage while maintaining effective bacterial killing.	LCP2 KIT	3.77e-05	3	124	2	17372019
Pubmed	Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer.	CHD1 KMT2A	3.77e-05	3	124	2	22046413
Pubmed	ANKS4B Is Essential for Intermicrovillar Adhesion Complex Formation.	MYO7B USH1C	3.77e-05	3	124	2	26812018
Pubmed	Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.	CBL KIT	3.77e-05	3	124	2	17904548
Pubmed	Neurofibromin as a regulator of melanocyte development and differentiation.	NF1 KIT	3.77e-05	3	124	2	18089649
Pubmed	The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1).	CD2AP CBL	3.77e-05	3	124	2	15001553
Pubmed	Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl).	CBL KIT	3.77e-05	3	124	2	15315962
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	PMS2 TRIO CD2AP KAT6A MAST2 CBL MADD KIAA0753 NUFIP1 CEP350 SYMPK	3.81e-05	689	124	11	36543142
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK ARHGAP32 TRIO MYO5A APC2 BCOR ZEB2 NCOR2 NF1 PI4KA ARHGAP44 PAK2 LRRC7	4.19e-05	963	124	13	28671696
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 PNN JMJD1C SEC24B NHS LRRC7 TANC1	4.63e-05	263	124	7	34702444
Pubmed	Quantitative interactomics in primary T cells unveils TCR signal diversification extent and dynamics.	THEMIS LCP2 CBL	4.82e-05	20	124	3	31591574
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLNA ARHGAP32 GAK SELENBP1 COPB1 TRIO MYO5A SPECC1 MADD NF1 PI4KA VCAN ARHGAP44 KMT2A LRRC7 TANC1	5.13e-05	1431	124	16	37142655
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	USP36 SP100 PMS2 TRIO BMS1 CHD1 GTF2E1 TANC1 SRRM2	5.18e-05	472	124	9	38943005
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	SP100 TOPBP1 CHD1 JMJD1C KMT2A SPEN	5.22e-05	183	124	6	36129980
Pubmed	Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.	FLNA CBL FASLG EGF PAK2 CD74 KIT PIK3R5	5.84e-05	371	124	8	25241761
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	USP36 FLNA MID2 MYO5A CD2AP CEP350 SH3PXD2A ASCC2 PAK2 SPEN YTHDF2	5.94e-05	724	124	11	36232890
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	FLNA PNN RRP1B BAG4 SEC24B COBL YTHDF2	5.99e-05	274	124	7	34244482
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TNIK GAK TRIO CHD1 JMJD1C MADD CEP350 MDC1 TANC1 USP1 YTHDF2	6.62e-05	733	124	11	34672954
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	TNIK ARHGAP32 TRIO MYO5A NF1 PI4KA LRRC7	7.02e-05	281	124	7	28706196
Interaction	NUP43 interactions	USP36 FLNA EME1 PNN RRP1B BMS1 TOPBP1 CHD1 BCOR JMJD1C FSIP2 NCOR2 PI4KA MDC1 KMT2A SRRM2 SPEN	1.39e-07	625	118	17	int:NUP43
Interaction	YWHAG interactions	FLNA ARHGAP32 COPB1 PNN DISC1 CD2AP MAST2 CBL TERF1 SPECC1 KIAA0753 CEP350 NF1 SH3PXD2A PI4KA SEC24B PAK2 KMT2A COBL NHS TANC1 ULK1 SRRM2 YTHDF2	2.03e-07	1248	118	24	int:YWHAG
Interaction	SH3GL2 interactions	TNIK CD2AP LCP2 MAST2 CBL TERF1 PAK2	8.46e-07	88	118	7	int:SH3GL2
Interaction	LYN interactions	TNIK ARHGAP32 TRIO SLITRK4 LCP2 CBL FASLG SPECC1 NF1 PI4KA BTK PAK2 KMT2A TANC1 ULK1 SRRM2 KIT	1.00e-06	720	118	17	int:LYN
Interaction	YWHAH interactions	ARHGAP32 PNN TRIO CD2AP MAST2 CBL SPECC1 MADD KIAA0753 CEP350 NF1 SH3PXD2A PI4KA SEC24B PAK2 KMT2A COBL NHS TANC1 SRRM2 YTHDF2	1.54e-06	1102	118	21	int:YWHAH
Interaction	ITK interactions	PNN LCP2 CBL FASLG BTK SRRM2	1.67e-06	62	118	6	int:ITK
Interaction	PML interactions	FLNA EME1 SP100 PMS2 CD2AP KAT6A TOPBP1 BCOR JMJD1C NCOR2 GTF2E1 INTS6 NF1 MDC1 SEC24B PAK2 KMT2A YTHDF2 SYMPK	1.98e-06	933	118	19	int:PML
Interaction	NCK2 interactions	TNIK ARHGAP32 DISC1 LCP2 CBL FASLG C4orf17 PAK2 NHS KIT	3.30e-06	262	118	10	int:NCK2
Interaction	YWHAZ interactions	ARHGAP32 COPB1 MYO5A DISC1 KAT6A BCOR LCP2 MAST2 CBL SPECC1 MADD FSIP2 NF1 RASAL3 SH3PXD2A MDC1 PAK2 KMT2A NHS CD74 TANC1 ULK1	7.30e-06	1319	118	22	int:YWHAZ
Interaction	BLNK interactions	CD2AP LCP2 CBL BTK KIT	8.85e-06	48	118	5	int:BLNK
Interaction	CRK interactions	FLNA ARHGAP32 CD2AP KAT6A BCOR CBL FASLG C4orf17 SPEN KIT ADGRL3	1.14e-05	370	118	11	int:CRK
Interaction	HCK interactions	MID2 CD2AP LCP2 CBL FASLG BTK PAK2 KIT	1.82e-05	193	118	8	int:HCK
Interaction	SMC5 interactions	USP36 FLNA PNN RRP1B DISC1 CD2AP TOPBP1 CHD1 BCOR SSX2 JMJD1C NCOR2 MDC1 KMT2A SRRM2 SPEN YTHDF2 SYMPK	2.04e-05	1000	118	18	int:SMC5
Interaction	SNRNP40 interactions	USP36 FLNA PNN RRP1B KAT6A BMS1 CHD1 BCOR NUFIP1 NCOR2 MDC1 KMT2A SRRM2 SPEN	2.18e-05	637	118	14	int:SNRNP40
Interaction	GRAP2 interactions	BEND5 BAG4 LCP2 CBL FASLG KIT	3.37e-05	104	118	6	int:GRAP2
Interaction	EN1 interactions	BRMS1L BCOR ZEB2 NCOR2 KMT2A SRRM2	4.63e-05	110	118	6	int:EN1
Interaction	MAPRE1 interactions	FLNA TRIO CD2AP APC2 CBL TERF1 SPECC1 CEP350 COBL WDR90 TANC1 SRRM2	4.90e-05	514	118	12	int:MAPRE1
Interaction	SFN interactions	TNIK ARHGAP32 CD2AP MAST2 CBL SPECC1 CEP350 SH3PXD2A PAK2 KMT2A COBL NHS TANC1 SRRM2	5.37e-05	692	118	14	int:SFN
Interaction	MAPRE3 interactions	TRIO APC2 CBL SPECC1 NUFIP1 CEP350 COBL TANC1	6.35e-05	230	118	8	int:MAPRE3
Interaction	GRIN2B interactions	TNIK ARHGAP32 ZEB2 NF1 LRRC7 TANC1 ADGRL3	6.45e-05	170	118	7	int:GRIN2B
Interaction	LCK interactions	ARHGAP32 TRIO MYO5A LCP2 CBL FASLG NF1 PI4KA PAK2 TANC1 KIT	8.79e-05	463	118	11	int:LCK
Interaction	TERF2IP interactions	SP100 OGFR TOPBP1 CHD1 BCOR TERF1 NCOR2 MDC1 KMT2A SRRM2 SPEN SYMPK	9.67e-05	552	118	12	int:TERF2IP
Interaction	TOP3B interactions	UNC13B SEMA6C FLNA MID2 TRIO KAT6A MAST2 MADD TBC1D16 NCOR2 PI4KA ARHGAP44 MDC1 SEC24B COBL WDR90 TANC1 ULK1 SPEN YTHDF2 SYMPK	1.17e-04	1470	118	21	int:TOP3B
Interaction	YWHAE interactions	FLNA ARHGAP32 DISC1 LCP2 MAST2 CBL SPECC1 NCOR2 NF1 RASAL3 SH3PXD2A PAK2 KMT2A NHS CD74 TANC1 ULK1 MERTK SRRM2	1.23e-04	1256	118	19	int:YWHAE
Interaction	CTBP1 interactions	TNIK PNN BCOR ZEB2 NCOR2 MDC1 KMT2A TSHZ1 SRRM2 SPEN	1.39e-04	406	118	10	int:CTBP1
Interaction	DPYSL3 interactions	TNIK DISC1 CBL TERF1 NUFIP1	1.51e-04	86	118	5	int:DPYSL3
Interaction	TANC2 interactions	TNIK FLNA NF1 SH3PXD2A TANC1	1.77e-04	89	118	5	int:TANC2
Interaction	TEC interactions	FASLG BTK KMT2A MERTK KIT	1.87e-04	90	118	5	int:TEC
Interaction	GRAP interactions	ARHGAP32 FASLG KIT	2.07e-04	20	118	3	int:GRAP
Interaction	BTK interactions	FLNA CBL FASLG BTK MERTK KIT	2.13e-04	145	118	6	int:BTK
Interaction	FYN interactions	ARHGAP32 PMS2 CD2AP BAG4 LCP2 CBL FASLG BTK PAK2 KIT	2.25e-04	431	118	10	int:FYN
Interaction	PARN interactions	USP36 BCOR JMJD1C NCOR2 MDC1 SYMPK	2.38e-04	148	118	6	int:PARN
Interaction	KALRN interactions	TNIK TRIO MYO5A DISC1 FASLG	2.53e-04	96	118	5	int:KALRN
Cytoband	8p23.1	FAM90A14 FAM90A17 FAM90A23 FAM90A8 FAM90A16	6.50e-05	154	124	5	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	FAM90A14 FAM90A17 FAM90A23 FAM90A8 FAM90A16	4.53e-04	234	124	5	chr8p23
GeneFamily	Sulfotransferases, cytosolic	SULT1B1 SULT1A1	1.13e-03	14	65	2	762
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB2 TSHZ1	1.30e-03	15	65	2	529
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SP100 TRIO CD2AP KAT6A TOPBP1 ARFGEF1 CHD1 MAST2 TERF1 ZEB2 SNX13 CEP350 NCOR2 DBF4 SEC24B SPEN	1.70e-06	856	119	16	M4500
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	PNN NCOR2 NF1 BTK SETBP1 COBL	5.44e-06	97	119	6	M14698
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	FLNA THEMIS COPB1 PNN MYO5A KAT6A CHD1 LCP2 CBL FASLG JMJD1C ZEB2 CEP350 RASAL3 PAK2 KMT2A SPEN USP1 KIT PIK3R5	1.24e-05	1492	119	20	M40023
Coexpression	GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP	SLC29A3 TOPBP1 ZEB2 NUFIP1 INTS6 KMT2A WDR90	3.69e-05	200	119	7	M7031
Coexpression	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP	PMS2 RBKS BRMS1L KIAA0753 WDR90 MERTK USP1	3.69e-05	200	119	7	M6542
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	ST6GALNAC1 PNN MYO5A ARFGEF1 CHD1 SPECC1 SNX13 CEP350 DBF4 ARHGAP44 USP1 KIT	4.53e-05	656	119	12	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TRIO CD2AP KAT6A TOPBP1 ARFGEF1 CHD1 SNX13 CEP350 SEC24B SPEN	5.42e-05	466	119	10	M13522
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	EME1 GAK COPB1 TRIO KAT6A TOPBP1 ARFGEF1 VPS54 JMJD1C KIAA0753 GTF2E1 DBF4 MDC1 SEC24B	2.77e-06	564	117	14	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3	EME1 SLC29A3 BEND5 LCP2 RASAL3 SH3PXD2A ASCC2 NHS CD74 CACNA1G TSHZ1 MERTK MRPL9 PIK3R5	2.94e-06	567	117	14	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DISC1 LCP2 CBL SPECC1 ZEB2 VCAN MERTK PIK3R5	5.83e-08	196	119	8	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS MYO5A LCP2 ZEB2 VCAN CD74 MERTK PIK3R5	6.06e-08	197	119	8	c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SP100 PNN CHD1 JMJD1C ZEB2 CEP350 KMT2A SRRM2	6.81e-08	200	119	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP36 FLNA C1orf54 CDS1 MYO5A CD74 ADGRL3	2.53e-07	160	119	7	e9e52532131cdc3fb01e81cfc046e3f670cc8e75
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP KAT6A CHD1 JMJD1C ZEB2 CEP350 KMT2A	6.50e-07	184	119	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C1orf54 CD2AP KAT6A CHD1 JMJD1C ZEB2 CEP350	6.74e-07	185	119	7	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ARFGEF1 CHD1 JMJD1C ZEB2 NF1 KMT2A SPEN	7.51e-07	188	119	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 BTK CD74 MERTK PIK3R5	8.64e-07	192	119	7	86d792682ba51696f503c79625dd20f87bcf651f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 BTK CD74 MERTK PIK3R5	8.64e-07	192	119	7	d0ad6a205ad50a3c523fa68676996b289eabc5de
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP KAT6A JMJD1C SNX13 CEP350 SRRM2 YTHDF2	8.95e-07	193	119	7	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP KAT6A JMJD1C SNX13 CEP350 SRRM2 YTHDF2	8.95e-07	193	119	7	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	Control-Myeloid-Monocyte-derived_macrophages\|Control / group, cell type (main and fine annotations)	MYO5A DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	8.95e-07	193	119	7	a6b3bd01e585e2e3fbe9bf693a2e385773123f8e
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP KAT6A JMJD1C SNX13 CEP350 SRRM2 YTHDF2	8.95e-07	193	119	7	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD2AP KAT6A JMJD1C SNX13 CEP350 SRRM2 YTHDF2	8.95e-07	193	119	7	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	9.27e-07	194	119	7	c95d5c4ad0210ebd672926558cc8331e6396a854
ToppCell	Children_(3_yrs)-Immune-monocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DISC1 LCP2 SPECC1 ZEB2 VCAN MERTK PIK3R5	9.59e-07	195	119	7	81a28289eda1a8a1a31b7357106f64ac5000e172
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	9.59e-07	195	119	7	42bfdff88da1d07828c0ad65d412fb1752f0cee4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	9.92e-07	196	119	7	cbc727b55b6433a701b1a331028a49960fcee6ee
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A LCP2 ZEB2 VCAN CD74 MERTK PIK3R5	1.03e-06	197	119	7	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK LCP2 SPECC1 ZEB2 ZSCAN10 BTK KIT	1.03e-06	197	119	7	bed8a9b73af5caee51b1232b31c24a59353658df
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS DISC1 LCP2 ZEB2 RASAL3 CD74 PIK3R5	1.03e-06	197	119	7	0523aec9713ae21e6b879aa98e07fa2576610d5f
ToppCell	Children_(3_yrs)-Immune\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5A DISC1 LCP2 CBL ZEB2 CD74 PIK3R5	1.03e-06	197	119	7	f18807124b91310fcd84238484a80ecdba684679
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK LCP2 SPECC1 ZEB2 ZSCAN10 BTK KIT	1.03e-06	197	119	7	b7d5073d44aa1e2cb83ea8d8104c5ed662665755
ToppCell	nucseq-Immune-Immune_Myeloid-IM\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5A DISC1 LCP2 ZEB2 TBC1D16 MERTK PIK3R5	1.03e-06	197	119	7	6f41c8f815851968849428ec92c16745bd01a3fb
ToppCell	nucseq-Immune-Immune_Myeloid-IM-IM\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5A DISC1 LCP2 ZEB2 TBC1D16 MERTK PIK3R5	1.03e-06	197	119	7	304044ace926943b8eb588f686ecbe5d1689a809
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	TNIK FLNA THEMIS LCP2 FASLG RASAL3 KMT2A	1.06e-06	198	119	7	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B ARHGAP32 TRIO LRRC37A3 NF1 ARHGAP44 TANC1	1.06e-06	198	119	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5A DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	1.14e-06	200	119	7	179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCell	Tracheal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LCP2 SPECC1 ZEB2 BTK CD74 MERTK PIK3R5	1.14e-06	200	119	7	ad7ae5106141669b353800fece833b3cd5bdccee
ToppCell	Children_(3_yrs)-Immune-monocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DISC1 LCP2 CBL ZEB2 VCAN MERTK PIK3R5	1.14e-06	200	119	7	881ab995c90d75fd987d6e8f1f926a4bfcc4235f
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5A DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	1.14e-06	200	119	7	ad52b38df5c71f28829b04cd0e6b97f0f9f7610a
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DISC1 LCP2 CBL ZEB2 VCAN BTK PIK3R5	1.14e-06	200	119	7	8872d5fa101d413fb43b4231d476878678543035
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5A DISC1 LCP2 ZEB2 VCAN CD74 PIK3R5	1.14e-06	200	119	7	46f9c28b24e39acdf0481a02b6eb86ecdd83c504
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	SP100 PNN CHD1 JMJD1C ZEB2 CD74 SRRM2	1.14e-06	200	119	7	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC29A3 ATXN7L2 CYP2E1 DISC1 BMS1 SEC24B	5.67e-06	166	119	6	de319c960b0cd90b294f677d1ea1b013a2ce2d53
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNIK SLITRK4 RBM23 BTK COBL KIT	5.67e-06	166	119	6	a42268a02a89fc97272e45c4cbe21acf04b7428c
ToppCell	PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	THEMIS LCP2 FASLG RASAL3 CD74 PIK3R5	6.07e-06	168	119	6	2ec53f91de3bff8a106430a78b81ee6870f0c55e
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA ATXN7L2 TERF1 ZEB2 ZNF469 PIK3R5	6.72e-06	171	119	6	187b396059f8802265f54bad2b4882cebb809419
ToppCell	COVID-19-lung-MAST\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TNIK SPECC1 ZEB2 BTK COBL KIT	7.92e-06	176	119	6	473c45a381ca109207d66ed1635668b391ea0e1f
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICDL2 CD2AP ZEB2 BTK SPEN CCDC158	8.18e-06	177	119	6	14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C1orf54 CD2AP KAT6A CHD1 ZEB2 CEP350	9.59e-06	182	119	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 CD2AP CHD1 JMJD1C CD74 SRRM2	9.59e-06	182	119	6	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 CD2AP CHD1 JMJD1C CD74 SRRM2	9.89e-06	183	119	6	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SP100 TRIO OGFR CD2AP JMJD1C CEP350	9.89e-06	183	119	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 CD2AP CHD1 JMJD1C CD74 SRRM2	9.89e-06	183	119	6	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	USP36 CHD1 LCP2 JMJD1C ZEB2 VCAN	1.02e-05	184	119	6	b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SP100 THEMIS DISC1 LCP2 RASAL3 PIK3R5	1.19e-05	189	119	6	df30478b288084a1bd48f660409dcc784040897c
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	USP36 CHD1 NCOR2 SH3PXD2A VCAN CACNA1G	1.19e-05	189	119	6	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS LCP2 FASLG ZEB2 RASAL3 PIK3R5	1.22e-05	190	119	6	4a75457652d85874d5c6a41648f8003572008b15
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5A DISC1 LCP2 ZEB2 MERTK PIK3R5	1.22e-05	190	119	6	2d54fca50593fbd11fe13fc2bfaf937a05db776d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS LCP2 FASLG ZEB2 RASAL3 PIK3R5	1.22e-05	190	119	6	cda6173634531240e0bab8766231a150ff8d0129
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	1.26e-05	191	119	6	51f5af610983aa73b9f4ece6f27d281ebff89a04
ToppCell	Control-Myeloid\|Control / group, cell type (main and fine annotations)	MYO5A DISC1 ZEB2 CD74 MERTK PIK3R5	1.26e-05	191	119	6	9c4acc5f3c2f9c0c5520863bb22f391774372347
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 BTK CD74 PIK3R5	1.26e-05	191	119	6	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	1.26e-05	191	119	6	8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS LCP2 ZEB2 BTK KIT PIK3R5	1.26e-05	191	119	6	468b5149d1533f03521844d3cce8633d44eb6ed4
ToppCell	PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	THEMIS CYP2E1 LCP2 FASLG RASAL3 PIK3R5	1.30e-05	192	119	6	42fed1a4c88e62dffda026503e5da1eb21fe877f
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	USP36 TNIK ARFGEF1 CHD1 JMJD1C KMT2A	1.30e-05	192	119	6	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)\|Adult / Lineage, Cell type, age group and donor	MYO5A DISC1 LCP2 ZEB2 MERTK PIK3R5	1.34e-05	193	119	6	31c0978ba78c9516d498aec0798902e57555e557
ToppCell	Immune-interstitial_macrophage_(C1Q_positive)\|World / Lineage, Cell type, age group and donor	MYO5A DISC1 ZEB2 CD74 MERTK PIK3R5	1.34e-05	193	119	6	64d598162a256ac6c9f8280c8a9133661dfbb10f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 BTK CD74 PIK3R5	1.34e-05	193	119	6	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	USP36 CHD1 NCOR2 SH3PXD2A VCAN CACNA1G	1.38e-05	194	119	6	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	MYO5A DISC1 LCP2 ZEB2 CD74 MERTK	1.38e-05	194	119	6	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS DISC1 LCP2 ZEB2 CD74 PIK3R5	1.38e-05	194	119	6	0866ab6792cee274a71991d5c37a37f574ff446e
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5A DISC1 LCP2 ZEB2 MERTK PIK3R5	1.38e-05	194	119	6	663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A DISC1 LCP2 ZEB2 MERTK PIK3R5	1.38e-05	194	119	6	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 BTK CD74 PIK3R5	1.38e-05	194	119	6	badefcec2af86cbcd97305f4843e84db0f3ebc66
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS DISC1 LCP2 RASAL3 BTK PIK3R5	1.42e-05	195	119	6	2d485373bfd9bb4bb9236bf0b31d03e132c8018f
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	MYO5A DISC1 LCP2 ZEB2 MERTK PIK3R5	1.42e-05	195	119	6	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A LCP2 ZEB2 CD74 MERTK PIK3R5	1.42e-05	195	119	6	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS DISC1 LCP2 ZEB2 RASAL3 PIK3R5	1.42e-05	195	119	6	ce8215d503cad3a9bc7d5d2be4adb57408015593
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO5A DISC1 LCP2 ZEB2 MERTK PIK3R5	1.42e-05	195	119	6	34a9462f4e843f3065cc58c17ad71c1b5b836ae1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 BTK CD74 PIK3R5	1.46e-05	196	119	6	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	MYO5A LCP2 ZEB2 CD74 MERTK PIK3R5	1.46e-05	196	119	6	a753d76d764c181eecb0e17a794a2e7d0ff70136
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO5A LCP2 ZEB2 CD74 MERTK PIK3R5	1.46e-05	196	119	6	1b7928f4eee94d4bb6ea410bab68a471dba12979
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	1.50e-05	197	119	6	6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|lung / Disease (COVID-19 only), tissue and cell type	MYO5A LCP2 ZEB2 VCAN MERTK PIK3R5	1.50e-05	197	119	6	3896729740d151f0eb845f1961c7b969bfbdd28d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 SPECC1 ZEB2 CD74 PIK3R5	1.50e-05	197	119	6	57dafb3047745a44b2345b8036e159c3641d496e
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	SP100 PNN CHD1 JMJD1C ZEB2 SRRM2	1.50e-05	197	119	6	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	background-Kupffer_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	MYO5A LCP2 ZEB2 CD74 MERTK PIK3R5	1.50e-05	197	119	6	8b45c7ecc18d188abc8c172d9bf881c95617a46a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DISC1 LCP2 SPECC1 ZEB2 CD74 PIK3R5	1.50e-05	197	119	6	826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d
ToppCell	Healthy/Control-cDC\|Healthy/Control / Disease group and Cell class	C1orf54 CDS1 CYP2E1 SPECC1 ZNF469 CD74	1.50e-05	197	119	6	926423aae9fcf654f84b0f7621103a6a22d3aced
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THEMIS DISC1 LCP2 ZEB2 RASAL3 PIK3R5	1.50e-05	197	119	6	61ef3f417767c3f5296a26399da63e3e4f58faf8
ToppCell	BL-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ST6GALNAC1 BICDL2 ARHGAP32 CDS1 SELENBP1 DNAI4	1.55e-05	198	119	6	6218a25b94d5fa2c69880539adf9c63bfe52dcd3
ToppCell	COVID-19-Myeloid\|COVID-19 / group, cell type (main and fine annotations)	MYO5A LCP2 ZEB2 CD74 MERTK PIK3R5	1.55e-05	198	119	6	33f0a919188a67d2a876b52c61a1cec2c9747969
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OGFR NT5C3B LCP2 ZEB2 MERTK PIK3R5	1.55e-05	198	119	6	2b724d2a36843801984d46a969d33149b76c9771
ToppCell	Immune\|World / Lineage, Cell type, age group and donor	MYO5A LCP2 CBL ZEB2 CD74 PIK3R5	1.55e-05	198	119	6	65681b54d13c6997bd90a1c2a12314a80e964fe3
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	FLNA SP100 CHD1 LCP2 ZEB2 SRRM2	1.55e-05	198	119	6	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	SP100 PNN CHD1 JMJD1C ZEB2 SRRM2	1.55e-05	198	119	6	44417089b62056269cac38d3134ff209c05b7007
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK LCP2 SPECC1 ZEB2 BTK KIT	1.55e-05	198	119	6	cc5ca64749e2f4f1d373d9472824df85741702b7
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK LCP2 SPECC1 ZEB2 BTK KIT	1.55e-05	198	119	6	d4d66f19df078bfc3a83d4664aaf9c7789bde1a5
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	MYO5A DISC1 LCP2 ZEB2 VCAN PIK3R5	1.55e-05	198	119	6	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DISC1 LCP2 ZEB2 CD74 MERTK PIK3R5	1.55e-05	198	119	6	0b928a829844f49f4d47e88908af192cb919011f
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5A DISC1 ZEB2 BTK MERTK PIK3R5	1.55e-05	198	119	6	0b41b3d6c2db795320e8b65d40d85fb8b618cc34
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SP100 PNN CHD1 JMJD1C ZEB2 SRRM2	1.55e-05	198	119	6	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Immune-monocyte\|World / Lineage, Cell type, age group and donor	DISC1 LCP2 SPECC1 ZEB2 VCAN PIK3R5	1.55e-05	198	119	6	d3622da252fd580f1dc5c7478a8e23df5ec083cf
ToppCell	CTRL-Myeloid\|CTRL / Disease state, Lineage and Cell class	FLNA TRIO MYO5A ZEB2 CD74 PIK3R5	1.59e-05	199	119	6	70b89a930709fdb91fde6f96106add8455b11618
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THEMIS LCP2 ZEB2 RASAL3 SETBP1 PIK3R5	1.59e-05	199	119	6	7d69785717073491b5fb81bf24db0175f86cd0b0
ToppCell	Parenchymal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5A DISC1 LCP2 ZEB2 BTK PIK3R5	1.59e-05	199	119	6	7ee2805fd9143eba11bf6832267b62189683608b
ToppCell	cellseq-Immune-Immune_Myeloid-IM\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5A LCP2 ZEB2 CD74 MERTK PIK3R5	1.59e-05	199	119	6	b3267d5a7ae0461f5e9e6a3ab6783317a8c42506
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A	TRIO RRP1B MAST2 CBL SNX13 CEP350 NF1 KDM8 SYMPK	8.25e-07	195	118	9	3835_DN
Drug	Thimerosal	MYO5A BAG4 KAT6A LRRC37A2 BCOR CBL SPECC1 JMJD1C CEP350 TBC1D16 FSIP2 INTS6 NF1 VSIG10L KMT2A LRRC7 SRRM2 SPEN USP1 ADGRL3	3.39e-06	1199	118	20	ctd:D013849
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ARHGAP32 PMS2 TRIO ARFGEF1 MADD CEP350 KMT2A SPEN	6.28e-06	188	118	8	4845_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	TRIO OGFR KAT6A KIAA0753 CEP350 NF1 VCAN KMT2A	7.05e-06	191	118	8	6644_DN
Drug	1-hydroxymethylpyrene	CYP2E1 SULT1B1 SULT1A1	7.46e-06	8	118	3	ctd:C065833
Drug	Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A	TRIO DISC1 SULT1B1 NF1 VCAN SETBP1 CD74 CYP4F11	8.21e-06	195	118	8	6415_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	USP36 MAST2 CBL NCOR2 NF1 KMT2A CYP4F11 SYMPK	9.18e-06	198	118	8	4729_DN
Drug	Adrenosterone [382-45-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	LUZP4 C1orf54 OGFR DISC1 KIAA0753 VCAN SETBP1 PIK3R5	9.18e-06	198	118	8	5464_UP
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	RRP1B DISC1 RBKS MAST2 MADD CEP350 EGF ASCC2	9.52e-06	199	118	8	5824_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; HL60; HT_HG-U133A	SP100 CDS1 CYP2E1 OGFR SULT1B1 SH3PXD2A KDM8 ADGRL3	9.52e-06	199	118	8	2715_DN
Drug	geldanamycin	USP36 MYO5A KAT6A BCOR CBL JMJD1C NF1 EGF KMT2A SRRM2	2.39e-05	371	118	10	ctd:C001277
Drug	anti-BaPDE	FLNA SELENBP1 CYP2E1 TOPBP1 VPS54 FASLG VCAN CYP4F11	3.06e-05	234	118	8	CID000041322
Drug	NSC226080	SELENBP1 MID2 MYO5A CBL FASLG INTS6 NF1 EGF VCAN PAK2 COBL ULK1 KIT PIK3R5	5.43e-05	782	118	14	CID000005040
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	TRIO KAT6A CEP350 NF1 VCAN KMT2A SRRM2	5.90e-05	189	118	7	6649_DN
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A	SP100 TRIO OGFR MAST2 NF1 EGF VCAN	5.90e-05	189	118	7	5084_DN
Drug	glycidamide	EME1 PMS2 SELENBP1 CYP2E1 SULT1A1 CYP4F11	6.03e-05	130	118	6	ctd:C071834
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	FLNA TRIO OGFR KAT6A CEP350 NF1 CD74	6.30e-05	191	118	7	6236_UP
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	SP100 OGFR KAT6A CBL SNX13 CEP350 KMT2A	6.51e-05	192	118	7	5058_DN
Drug	LY-171,883; Down 200; 1uM; MCF7; HG-U133A	C1orf54 SP100 DISC1 NF1 SETBP1 COBL ADGRL3	6.95e-05	194	118	7	222_DN
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A	TNIK SP100 RRP1B KAT6A CBL SULT1B1 NF1	7.18e-05	195	118	7	5093_DN
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A	PMS2 RRP1B ARFGEF1 RBKS NF1 VCAN SYMPK	7.41e-05	196	118	7	1182_DN
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; HL60; HT_HG-U133A	C1orf54 BAG4 ARFGEF1 RBKS KIAA0753 NF1 ULK1	7.41e-05	196	118	7	2506_DN
Drug	Flurbiprofen [5104-49-4]; Down 200; 16.4uM; HL60; HT_HG-U133A	BEND5 CBL SNX13 NF1 ARHGAP44 KMT2A ADGRL3	7.41e-05	196	118	7	3095_DN
Drug	Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HT_HG-U133A	SP100 SLC29A3 CYP2E1 OGFR NF1 ADGRL3 SYMPK	7.65e-05	197	118	7	4631_DN
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; HL60; HT_HG-U133A	OGFR KAT6A SNX13 SULT1B1 VCAN SRRM2 SYMPK	7.65e-05	197	118	7	2133_DN
Drug	0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A	CDS1 SLC29A3 CYP2E1 OGFR MAST2 VCAN SYMPK	7.65e-05	197	118	7	7069_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; HL60; HT_HG-U133A	SP100 OGFR KAT6A CEP350 NF1 SRRM2 SPEN	7.65e-05	197	118	7	2353_UP
Drug	Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	CYP2E1 OGFR NF1 VCAN KMT2A COBL PIK3R5	7.90e-05	198	118	7	5102_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SP100 OGFR KAT6A MAST2 CBL SULT1B1 DNAI4	7.90e-05	198	118	7	6053_DN
Drug	Troleandomycin [2751-09-9]; Up 200; 5uM; HL60; HG-U133A	MID2 TRIO RBKS BCOR MAST2 CBL SULT1B1	7.90e-05	198	118	7	1965_UP
Drug	Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A	OGFR BAG4 NCOR2 NF1 KDM8 MERTK CYP4F11	7.90e-05	198	118	7	4698_DN
Drug	1-methylpyrene	CYP2E1 SULT1A1	7.96e-05	3	118	2	ctd:C053035
Drug	5-hydroxy-3-methylindole	CYP2E1 SULT1A1	7.96e-05	3	118	2	CID000192734
Drug	Iopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A	SP100 TRIO OGFR BAG4 CEP350 COBL ULK1	8.15e-05	199	118	7	5832_DN
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	C1orf54 CYP2E1 DISC1 MAST2 NF1 KMT2A KDM8	8.15e-05	199	118	7	2243_DN
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; HL60; HT_HG-U133A	USP36 SLC29A3 MAST2 KIAA0753 NF1 DNAI4 ULK1	8.15e-05	199	118	7	2341_UP
Drug	EKB-569	TNIK GAK EGF BTK KIT	9.04e-05	87	118	5	CID006445562
Disease	Malignant neoplasm of breast	FLNA CDS1 APC2 LRRC37A2 ZEB2 NF1 LRRC37A EGF SULT1A1 BTK SETBP1 NHS CD74 LRRC7 SPEN KIT MRPL9	1.19e-06	1074	117	17	C0006142
Disease	Breast Carcinoma	FLNA APC2 LRRC37A2 ZEB2 LRRC37A EGF SULT1A1 BTK SETBP1 CD74 KIT MRPL9	1.61e-06	538	117	12	C0678222
Disease	Leukemia, Myelocytic, Acute	TRIO BCOR CBL NF1 SETBP1 KMT2A KIT	6.08e-06	173	117	7	C0023467
Disease	Mammary Carcinoma, Human	FLNA APC2 LRRC37A2 ZEB2 LRRC37A EGF SULT1A1 SETBP1 CD74 KIT MRPL9	8.10e-06	525	117	11	C4704874
Disease	Mammary Neoplasms, Human	FLNA APC2 LRRC37A2 ZEB2 LRRC37A EGF SULT1A1 SETBP1 CD74 KIT MRPL9	8.10e-06	525	117	11	C1257931
Disease	Mammary Neoplasms	FLNA APC2 LRRC37A2 ZEB2 LRRC37A EGF SULT1A1 SETBP1 CD74 KIT MRPL9	8.39e-06	527	117	11	C1458155
Disease	acute myeloid leukemia (is_implicated_in)	KAT6A CBL NF1 KMT2A KIT	2.16e-05	84	117	5	DOID:9119 (is_implicated_in)
Disease	Juvenile Myelomonocytic Leukemia	CBL NF1 SETBP1	5.62e-05	19	117	3	C0349639
Disease	JUVENILE MYELOMONOCYTIC LEUKEMIA	CBL NF1	9.30e-05	4	117	2	607785
Disease	Malignant Peripheral Nerve Sheath Tumor	NF1 SH3PXD2A	9.30e-05	4	117	2	C0751690
Disease	Juvenile myelomonocytic leukemia	CBL NF1	9.30e-05	4	117	2	cv:C0349639
Disease	Acute myelomonocytic leukemia	KMT2A KIT	1.55e-04	5	117	2	C0023479
Disease	Myelomonocytic leukemia	CBL SETBP1	1.55e-04	5	117	2	C0027019
Disease	white matter microstructure measurement	TNIK DISC1 MAST2 AXDND1 SH3PXD2A VCAN SETBP1 PAK2	1.69e-04	390	117	8	EFO_0005674
Disease	reticulocyte measurement	FLNA COPB1 CBL SPECC1 JMJD1C ZEB2 SNX13 NUFIP1 ZNF469 EGF SETBP1 ASCC2 PAK2	2.84e-04	1053	117	13	EFO_0010700
Disease	liver disease (biomarker_via_orthology)	CYP2E1 FASLG	3.23e-04	7	117	2	DOID:409 (biomarker_via_orthology)
Disease	juvenile myelomonocytic leukemia (is_implicated_in)	CBL NF1	3.23e-04	7	117	2	DOID:0050458 (is_implicated_in)
Disease	Colorectal Carcinoma	UNC13B PMS2 SELENBP1 APC2 ARFGEF1 CHD1 ZEB2 NF1 SETBP1 PIK3R5	4.95e-04	702	117	10	C0009402
Disease	high grade glioma (is_implicated_in)	CYP2E1 NF1 EGF	6.23e-04	42	117	3	DOID:3070 (is_implicated_in)
Disease	Adenoid Cystic Carcinoma	KAT6A BCOR JMJD1C VCAN	6.87e-04	100	117	4	C0010606
Disease	Prostatic Neoplasms	CYP2E1 KAT6A CHD1 FASLG SSX2 EGF SULT1A1 KMT2A SPEN	7.96e-04	616	117	9	C0033578
Disease	Malignant neoplasm of prostate	CYP2E1 KAT6A CHD1 FASLG SSX2 EGF SULT1A1 KMT2A SPEN	7.96e-04	616	117	9	C0376358
Disease	developmental disorder of mental health (implicated_via_orthology)	NCOR2 RASAL3 TANC1	9.80e-04	49	117	3	DOID:0060037 (implicated_via_orthology)
Disease	airway wall thickness measurement	NT5C3B C10orf90	1.00e-03	12	117	2	EFO_0006898
Disease	hemoglobin A1 measurement	MAST2 SPECC1 JMJD1C MADD EGF ASCC2 PAK2 YTHDF2	1.12e-03	520	117	8	EFO_0007629
Disease	Carcinoma, Granular Cell	SELENBP1 CYP2E1 EGF KMT2A	1.19e-03	116	117	4	C0205644
Disease	Adenocarcinoma, Tubular	SELENBP1 CYP2E1 EGF KMT2A	1.19e-03	116	117	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	SELENBP1 CYP2E1 EGF KMT2A	1.19e-03	116	117	4	C0205642
Disease	Carcinoma, Cribriform	SELENBP1 CYP2E1 EGF KMT2A	1.19e-03	116	117	4	C0205643
Disease	Adenocarcinoma, Basal Cell	SELENBP1 CYP2E1 EGF KMT2A	1.19e-03	116	117	4	C0205641
Disease	Adenocarcinoma	SELENBP1 CYP2E1 EGF KMT2A	1.19e-03	116	117	4	C0001418
Disease	white matter hyperintensity measurement	C1orf54 NCOR2 SULT1B1 SH3PXD2A VCAN SETBP1	1.32e-03	302	117	6	EFO_0005665
Disease	Acute Myeloid Leukemia, M1	TRIO NF1 KMT2A KIT	1.57e-03	125	117	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	TRIO NF1 KMT2A KIT	1.57e-03	125	117	4	C1879321
Disease	RASopathy	CBL NF1	1.58e-03	15	117	2	cv:C5555857
Disease	teratocarcinoma-derived growth factor 1 measurement	MYO5A KMT2A	1.80e-03	16	117	2	EFO_0008297
Disease	Chromosome Aberrations	SULT1A1 KMT2A	1.80e-03	16	117	2	C0008625
Disease	Autosome Abnormalities	SULT1A1 KMT2A	1.80e-03	16	117	2	C0004403
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO SRRM2	2.04e-03	17	117	2	DOID:0060307 (is_implicated_in)
Disease	Myeloid Leukemia	SETBP1 KMT2A	2.29e-03	18	117	2	C0023470
Disease	Leukemia, Monocytic, Chronic	SETBP1 KMT2A	2.29e-03	18	117	2	C0023466
Disease	Profound Mental Retardation	DISC1 NF1 SETBP1 CACNA1G	2.32e-03	139	117	4	C0020796
Disease	Mental Retardation, Psychosocial	DISC1 NF1 SETBP1 CACNA1G	2.32e-03	139	117	4	C0025363
Disease	Mental deficiency	DISC1 NF1 SETBP1 CACNA1G	2.32e-03	139	117	4	C0917816
Disease	Parkinson's disease (is_marker_for)	FASLG EGF SRRM2	2.42e-03	67	117	3	DOID:14330 (is_marker_for)
Disease	Schizophrenia	ST6GALNAC1 TNIK ARHGAP32 SELENBP1 CYP2E1 DISC1 SH3PXD2A PI4KA PAK2 KMT2A	2.74e-03	883	117	10	C0036341
Disease	stomach cancer (is_implicated_in)	CYP2E1 BCOR SULT1A1	2.97e-03	72	117	3	DOID:10534 (is_implicated_in)
Disease	reticulocyte count	COPB1 CD2AP MAST2 CBL SPECC1 JMJD1C NUFIP1 ZNF469 EGF SETBP1 ASCC2	2.97e-03	1045	117	11	EFO_0007986
Disease	Anophthalmia-microphthalmia syndrome	BCOR NHS	3.12e-03	21	117	2	cv:C5680330
Disease	serum non-albumin protein measurement	SP100 KAT6A MAST2 TBC1D16 NCOR2 EGF	3.23e-03	361	117	6	EFO_0004568
Disease	glucagon measurement	TNIK C10orf90 ZNF469 KDM8	3.35e-03	154	117	4	EFO_0008463
Disease	urinary bladder cancer (is_implicated_in)	PMS2 FASLG SULT1A1	3.46e-03	76	117	3	DOID:11054 (is_implicated_in)
Disease	Non-Small Cell Lung Carcinoma	CYP2E1 FASLG CD74 KIT	3.51e-03	156	117	4	C0007131
Disease	Hereditary Paraganglioma-Pheochromocytoma Syndrome	NF1 MERTK	3.73e-03	23	117	2	C1708353

Protein segments in the cluster

Peptide	Gene	Start	Entry
LPKTITAEVHPVPLR	USH1C	386	Q9Y6N9
PKPPLSPHKLSIVRE	BEND5	356	Q7L4P6
PSDESTPPSIKKIIH	BAG4	371	O95429
PIEIDPHRTVKEKLP	NT5C3B	86	Q969T7
IPPSSDRTPEILKKA	CDS1	61	Q92903
KHIPSKEFPVTETPL	VCAN	506	P13611
SSAITKKPPLIDREP	VCAN	1226	P13611
HRKTKKPLPPTPEED	BTK	181	Q06187
GPPDPKSHELRSKIL	ARFGEF1	441	Q9Y6D6
PKTGKLRTSPALHPE	ASCC2	16	Q9H1I8
PPIHLDSELERPSVK	ADGRL3	411	Q9HAR2
ETLKPDPHLRKSPSL	SPECC1	901	Q5M775
PTHSPEKILKLPKEE	CD2AP	511	Q9Y5K6
KKHHIPVVDRTPLEP	BMS1	66	Q14692
PHTPIEITKEEKPER	BCOR	731	Q6W2J9
EKKLLFISEPIPHPS	DBF4	406	Q9UBU7
LIPLHKSIPSDPEER	CHD1	1221	O14646
PIPPRLHSEDKRKTP	DISC1	731	Q9NRI5
EKEPSGTRLPPKTHR	ATXN7L2	216	Q5T6C5
APRDLPKHTPLISKS	RASAL3	771	Q86YV0
KSPHFREKSPVREPV	RBM23	141	Q86U06
KPLVDPKDIDLSPIH	CYP2E1	461	P05181
PDLIKPLPLHKISET	INTS6	691	Q9UL03
KLTLSEKVPPNHPSR	LUZP4	6	Q9P127
QTEPEPKHIPTEKVK	RBKS	246	Q9H477
EPLLVVKPTHSRPEG	FAM90A23	221	A8MXZ1
ETGVSHLRPEPPKIL	FAM47C	516	Q5HY64
EKPVSPPPIESKHRS	NCOR2	211	Q9Y618
PKRTIVSPKHPEVTL	LRRC37A3	631	O60309
SVIKHSPTVKREPPS	MADD	916	Q8WXG6
SELEPFHPKPKIRTR	MDC1	1096	Q14676
PKRTIVSPKHPEVTL	LRRC37A2	631	A6NM11
PKRTIVSPKHPEVTL	LRRC37A	631	A6NMS7
PPSIHPGKSDLIVRV	KIT	36	P10721
VESKPLPPLAFKHTV	MERTK	86	Q12866
PTTSPLPERKEHIKE	LRRC7	866	Q96NW7
DKLHKRSPPPETIKS	JMJD1C	611	Q15652
PDVKLEKTVPRLHRP	KDM8	176	Q8N371
EVKLKEPHISPIAPI	FSIP2	1766	Q5CZC0
TDVPLPKPSHADKLS	FSIP2	6161	Q5CZC0
EPLLVVKPTHSRPEG	FAM90A14	221	P0C7W9
PVEPVLTVHPESKSK	PNN	541	Q9H307
LKLVEKPSPLTLAPH	COPB1	766	P53618
EESLLSKLFPKIPPH	PI4KA	201	P42356
EPLLVVKPTHSRPEG	FAM90A17	221	P0DV74
SIVPPPKPERSHSLK	ARHGAP32	1976	A7KAX9
EPLLVVKPTHSRPEG	FAM90A16	221	P0DV73
EPLLVVKPTHSRPEG	FAM90A8	221	A6NJQ4
VSLLPHEKDKPVAEP	KAT6A	191	Q92794
PSVPEEKKPRHKIIS	PAK2	41	Q13177
EPITPHSKPILVRAV	GAK	566	O14976
EAATKKPLPPLRHLD	APC2	751	O95996
PTVHTSPPPETLKEK	CACNA1G	591	O43497
LKPSSLVVVHPLAKP	EGF	726	P01133
PRSPFKVKVLPTHDA	FLNA	1531	P21333
IVPHKPKTLTDTLIP	AXDND1	161	Q5T1B0
ILPTHTEPRRKPELI	CYP4F11	491	Q9HBI6
VPPRPHSEPSRKIKE	C4orf17	106	Q53FE4
KPVVQRPVPKDTSLH	COBL	1096	O75128
KPKIKPLTPLHRSET	CEP350	2131	Q5VT06
IAKPTVDTKPPVAHT	CFAP97D1	41	B2RV13
LEPPKKRTSLSPAEI	BICDL2	341	A1A5D9
DLPHSELKKELPPRE	MAST2	1431	Q6P0Q8
HPDPLTGTAKPSKLL	DNAI4	131	Q5VTH9
TTPPHLKPATEKLIV	KMT2A	3066	Q03164
PHRVKTEPPVKLEKH	BRMS1L	236	Q5PSV4
SLHKDKPLPVPPTLR	CBL	526	P22681
KIPEVPLHDTPERSA	EME1	141	Q96AY2
HSLEQKPTDAPPKVL	CD74	196	P04233
LDSPRKIIPSPGKEH	CCDC158	61	Q5M9N0
EPLLVVKPTHSRPEG	FAM90A5P	221	A8MXJ8
RPLSPILHIVKDESP	SEC24B	1221	O95487
EPLLVVKPTHSRPEG	FAM90A24P	221	P0C7X0
PPELPKSTEIHEQKR	MUCL3	71	Q3MIW9
KPSSLPHPLEGSRKV	OGFR	296	Q9NZT2
PEPTEIPALKQSKDH	GTF2E1	206	P29083
IDSHTPPLRPILKKT	SLC29A3	291	Q9BZD2
PLIPKTDSDPEHRRV	SNX13	756	Q9Y5W8
LHRLVTKPPKTTNPS	SLITRK4	296	Q8IW52
DPEQKPLHGVLKTPT	RRP1B	716	Q14684
DTKVKPETPPRQSHS	SRRM2	976	Q9UQ35
SKDLELPIIPPTHLD	NHS	1076	Q6T4R5
EPLLVVKPTHSRPEG	FAM90A12P	221	A8MX19
EPLLVVKPTHSRPEG	FAM90A13P	221	P0C7W8
LPSFIKEPQTKPSRH	ST6GALNAC1	31	Q9NSC7
PAHPLPSKTKTTERL	TANC1	1616	Q9C0D5
SEPRAPKLHKVIEPK	SELENBP1	111	Q13228
KISAISEKPLSPHPI	KIAA0753	816	Q2KHM9
SEKPLSPHPIRITKT	KIAA0753	821	Q2KHM9
PHTLRKVSKKLAPIP	ARHGAP44	641	Q17R89
EPLLVVKPTHSRPEG	FAM90A15P	221	P0C7V4
PSPRIVKTHLPTDLL	SULT1B1	101	O43704
ETARADHPKPVTVKP	C1orf54	81	Q8WWF1
LPIRTSKKQFTIPHP	C10orf90	616	Q96M02
VAPHTLKLPEEPITR	MRPL9	201	Q9BYD2
RPPKHPSVEETKLTL	THEMIS	556	Q8N1K5
VLPHEPAKVKPEESR	TNIK	771	Q9UKE5
HVRFPSESLKVPSKP	WDR90	221	Q96KV7
HSPKKELPAEEPSVL	ZSCAN10	106	Q96SZ4
RPSLEKPEPIHLSVS	SPEN	2906	Q96T58
EKPQHSVIPKEVTPA	NUFIP1	346	Q9UHK0
PPGKPTTSEKIHERS	SSX2	141	Q16385
DTAKPGKLHTIPIPV	PIK3R5	271	Q8WYR1
SPVRPKPIEKSQFIH	SH3PXD2A	1056	Q5TCZ1
LKDTPAPRLLKTHLP	SULT1A1	96	P50225
ELLHSSSLVKPPAPK	THAP5	141	Q7Z6K1
PEPPSTRKKRILESH	SP100	676	P23497
IRRPKLPSSETHPEE	TBC1D16	376	Q8TBP0
PDSIPQHTKIRPKDV	NF1	1836	P21359
VLPRDKDTPLSHIEP	SERPINE3	261	A8MV23
PESTPELPVKHLRAA	SEMA6C	701	Q9H3T2
PTPHKILLDTRFELP	UNC13B	116	O14795
RIPVSKSQPVTPEKH	TERF1	361	P54274
HSLTDKVPPSPELVK	SYMPK	861	Q92797
PPPEKKELRKVAHLT	FASLG	136	P48023
ENKPHSPKTPEPRRS	PMS2	431	P54278
SLHKSLTKILPERPP	ZNF469	371	Q96JG9
EKKKHPSTLVPVVTP	VSIG10L	811	Q86VR7
PNKKPFTSHRLVEPV	MID2	171	Q9UJV3
PPLRLTKPSHFTNIK	ZEB2	756	O60315
EPKTAIKHPRPVSSQ	SETBP1	741	Q9Y6X0
PLQKEPSLHLDTPSK	TOPBP1	811	Q92547
PKHPISEELETPIKD	TOPBP1	1211	Q92547
SDLHVVRPKLPKPPT	ULK1	561	O75385
HLGKVSKPVSPSLDP	TSHZ1	756	Q6ZSZ6
SLPGRPSVIPDHSKK	USP36	441	Q9P275
VAELPTKVEEIPHPK	USP1	226	O94782
TPSEPHPVLEKLRSI	YTHDF2	381	Q9Y5A9
LKEPIHIPKTAPATR	TRIO	1601	O75962
KIEVDPSKHIRPVPS	VPS54	21	Q9P1Q0
TERHERSSPLPGKKP	LCP2	291	Q13094
IPSRTEEPSEKKVPL	MYO5A	1136	Q9Y4I1
TEPRPEEPPKEKLHT	MYO7B	1596	Q6PIF6